Gene · 396
Papers1,898
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 1,898
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Proteotypic Differences of Follicular-Patterned Thyroid Neoplasms. | Front Endocrinol (Lausanne) | 2022 | 35923625 | PubTator, text mining | PubMed |
| Golgi stress induces SIRT2 to counteract Shigella infection via defatty-acylation. | Nat Commun | 2022 | 35918380 | PubTator, text mining | PubMed |
| Monogenic focal segmental glomerulosclerosis: A conceptual framework for identification and management of a heterogeneous disease. | Am J Med Genet C Semin Med Genet | 2022 | 35894442 | PubTator, text mining | PubMed |
| lncRNA-miRNA-mRNA ceRNA Network Involved in Sheep Prolificacy: An Integrated Approach. | Genes (Basel) | 2022 | 35893032 | PubTator, text mining | PubMed |
| Erectile Dysfunction: Key Role of Cavernous Smooth Muscle Cells. | Front Pharmacol | 2022 | 35865945 | PubTator, text mining | PubMed |
| The Effects of Poria cocos on Rho Signaling-Induced Regulation of Mobility and F-Actin Aggregation in MK-801-Treated B35 and C6 Cells. | Behav Neurol | 2022 | 35864844 | PubTator, text mining | PubMed |
| Gitelman's and Bartter's Syndromes: From Genetics to the Molecular Basis of Hypertension and More. | Kidney Blood Press Res | 2022 | 35858584 | PubTator, text mining | PubMed |
| Functions and mechanisms of N6‑methyladenosine in prostate cancer (Review). | Mol Med Rep | 2022 | 35856412 | PubTator, text mining | PubMed |
| An optimized bicistronic chimeric antigen receptor against GPC2 or CD276 overcomes heterogeneous expression in neuroblastoma. | J Clin Invest | 2022 | 35852863 | PubTator, text mining | PubMed |
| Subacute and chronic proteomic and phosphoproteomic analyses of a mouse model of traumatic brain injury at two timepoints and comparison with chronic traumatic encephalopathy in human samples. | Mol Brain | 2022 | 35850691 | PubTator, text mining | PubMed |
| RhoGDI1 interacts with PHLDA2, suppresses the proliferation, migration, and invasion of trophoblast cells, and participates in the pathogenesis of preeclampsia. | Hum Cell | 2022 | 35841528 | PubTator, text mining | PubMed |
| Integrative Network Modeling Highlights the Crucial Roles of Rho-GDI Signaling Pathway in the Progression of non-Small Cell Lung Cancer. | IEEE J Biomed Health Inform | 2022 | 35820010 | PubTator, text mining | PubMed |
| The Role of MicroRNA in the Regulation of Tumor Epithelial-Mesenchymal Transition. | Cells | 2022 | 35805066 | PubTator, text mining | PubMed |
| Antitumoral Effects of Tricyclic Antidepressants: Beyond Neuropathic Pain Treatment. | Cancers (Basel) | 2022 | 35805019 | PubTator, text mining | PubMed |
| 2D-DIGE-MS Proteomics Approaches for Identification of Gelsolin and Peroxiredoxin 4 with Lymph Node Metastasis in Colorectal Cancer. | Cancers (Basel) | 2022 | 35804959 | PubTator, text mining | PubMed |
| Ubiquitin ligase DTX3 empowers mutant p53 to promote ovarian cancer development. | Genes Dis | 2022 | 35782979 | PubTator, text mining | PubMed |
| RhoA signaling increases mitophagy and protects cardiomyocytes against ischemia by stabilizing PINK1 protein and recruiting Parkin to mitochondria. | Cell Death Differ | 2022 | 35760846 | PubTator, text mining | PubMed |
| Neuropilin-2 regulates androgen-receptor transcriptional activity in advanced prostate cancer. | Oncogene | 2022 | 35754042 | PubTator, text mining | PubMed |
| CRISPR/CasRx-Mediated RNA Knockdown Reveals That ACE2 Is Involved in the Regulation of Oligodendroglial Cell Morphological Differentiation. | Noncoding RNA | 2022 | 35736639 | PubTator, text mining | PubMed |
| Implementing a preimplantation proteomic approach to advance assisted reproduction technologies in the framework of predictive, preventive, and personalized medicine. | EPMA J | 2022 | 35719135 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/396/papers?page=11